Transcript mutations of the α regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes

Lancet

Volumn 360, Issue 9336, 2002, Pages 842-849

  Laxminarayana, Dama ^a   Khan, Islam U ^a   Kammer, Gary M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; MESSENGER RNA; RNA;

ARTICLE; CLINICAL ARTICLE; CODING; CONTROLLED STUDY; DNA SEQUENCE; ENZYME REGULATION; FEMALE; GENE DELETION; GENE MUTATION; GENETIC PARAMETERS; GENETIC TRANSCRIPTION; HEALTH STATUS; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA ANALYSIS; RNA EDITING; SEQUENCE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPREGULATION;

EID: 0037077866     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09966-X     Document Type: Article

References (30)

1. Kammer G.M., Perl A., Richardson B.C., Tsokos G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46:2002;1139-1154.
2. Mandler R., Birch R.E., Polmar S., Kammer G.M., Rudolph S.A. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proc Natl Acad Sci USA. 79:1982;7542-7546.
3. Hasler P., Schultz L.A., Kammer G.M. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. Proc Natl Acad Sci USA. 87:1990;1978-1982.
4. Kammer G.M., Khan I.U., Malemud C.J. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest. 94:1994;422-430.
5. Kammer G.M., Khan I.U., Kammer J.A., Olorenshaw I., Mathis D. Deficient type I protein kinase A activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics. J Immunol. 157:1996;2690-2698.
6. Laxminarayana D., Khan I.U., Mishra N., Olorenshaw I., Taskén K., Kammer G.M. Diminished levels of protein kinase A RIα and RIβ transcripts and proteins in systemic lupus erythematosus T lymphocytes. J Immunol. 162:1999;5639-5648.
7. Mishra N., Khan I.U., Tsokos G.C., Kammer G.M. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RIIβ-subunit in systemic lupus erythematosus T lymphocytes. J Immunol. 165:2000;2830-2840.
8. Kammer G.M. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arthritis Rheum. 42:1999;1458-1465.
9. Kammer G.M., Tsokos G.C. Abnormal T lymphocyte signal transduction in systemic lupus erythematosus. Curr Dir Autoimmun. 5:2002;131-150.
10. Maas S., Rich A. Changing genetic information through RNA editing. BioEssays. 22:2000;790-802.
11. Davidson N.O. The challenge of target sequence specificity in C to U RNA editing. J Clin Invest. 109:2002;291-294.
12. Gmelig-Meyling F., Dawisha S., Steinberg A.D. Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J Exp Med. 175:1992;297-300.
13. Nambiar M.P., Enyedy E.J., Warke V.G., et al. Polymorphisms/mutations of the TCR-z- chain promoter and 39 untranslated region and selective expression of TCR-z-chain with an alternatively spliced 39 untranslated region in patients with systemic lupus erythematosus. J Autoimmun. 16:2001;133-142.
14. Jacob A.M., Hansen A., Burmester G.R., Dörner T., Lipsky P.E. Enhanced mutational activity and disturbed selection of mutations in VH gene rearrangements in a patient with systemic lupus erythematosus. Autoimmunity. 33:2001;61-76.
15. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Ann Rev Biochem. 71:2002;817-846.
16. Laxminarayana D., Kammer G.M. mRNA mutations of the RIα-subunit of type I protein kinase A in T lymphocytes of subjects with systemic lupus erythematosus. Int Immunol. 12:2000;1521-1529.
17. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
18. Committee on Prognosis Studies in SLE, Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 35:1992;630.
19. Khan I.U., Laxminarayana D., Kammer G.M. A genetic mechanism underlying deficient type I protein kinase a activity in systemic lupus erythematosus T lymphocytes. Kammer G.M., Tsokos G.C., Lupus: Molecular and Cellular Pathogenesis. 1 edn: 1999;257-277 Humana Press, Totowa, NJ.
20. Lee J., Monson N.L., Lipsky P.E. The VlJl repertoire in human fetal spleen: evidence for positive and extensive receptor editing. J Immunol. 165:2000;6322-6333.
21. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., et al. Frameshift mutants of b amyloid precursor protein and ubiquitin-b in Alzheimer's and Down patients. Science. 279:1999;242-247.
22. van Leeuwen F.W., Burbach J.P., Hol E.M. Mutations in RNA: a first example of molecular misreadings in Alzheimer's disease. Trends Neurosci. 21:1999;331-335.
23. Solberg R., Sandberg M., Natarajan V., et al. The human gene for the regulatory subunit RIα of cyclic adenosine 39,59-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids. Endocrinology. 138:1997;169-181.
24. Solberg R., Sandberg M., Spurkland A., Jahnsen T. Isolation and characterization of a human pseudogene for the regulatory subunit RIα of cAMP-dependent protein kinases and its sublocalization on chromosome 1. Genomics. 15:1993;591-597.
25. Sale J.E., Calandrini D.M., Takara M., Takeda S., Neuberger M.S. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature. 412:2001;921-926.
26. Yoshikawa K., Okazaki I., Eto T., et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science. 296:2002;2033-2036.
27. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 301:1979;5-8.
28. Ronnblom L.E., Alm G.V. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 22:2001;427-431.
29. Reuter S.M., Dawson T.R., Emeson R.B. Regulation of alternative splicing by RNA editing. Nature. 399:1999;75-80.
30. Morse D.P., Aruscavage P.J., Bass B.L. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deminases that act on RNA. Proc Natl Acad Sci USA. 99:2002;7906-7911.